Althea Technologies, Inc.
http://www.altheatech.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Althea Technologies, Inc.
Seventeen And Counting – Bumper Crop Of New EU Filings
Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.
China First Domestic COVID-19 Antibody Therapy Moves Towards Green Light
Brii’s antibody combo therapy nears approval in China, based on data from a late-stage study conducted outside the country.
Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology
French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.
Lilly Pulls COVID-19 Antibody Treatment From EU Review
While Lilly's antibody combination of etesevimab and bamlanivimab is still going strong in the US, the company has lost out to Roche's Ronapreve in the EU.
Company Information
- Other Names / Subsidiaries
-
- Altus Pharmaceuticals Inc.